Portland’s zine culture stepped up in 2025, offering all manner of community action resources and supports.

Project 2025 initiated a war on reproductive rights that could escalate into even higher gear in 2026.

YouTube video by George Will Analysis

A leaked Justice Department memo directs federal prosecutors to press “domestic terrorism” charges against individuals who record immigration operations.

Prominent journalist Wajahat Ali fired off at President Donald Trump Friday after video resurfaced of Paula White – the White House spiritual adviser – comparing Trump to God.“To say no to President T...

Several major retailers are now charging customers to return items even if they are unopened and in perfect condition.

Mark Zuckerberg and current and former Meta executives agreed on Thursday to settle a $8 billion shareholder lawsuit alleging the company’s directors failed to prevent billions of dollars in fines and...

The Black Zine Fair was founded by Mariame Kaba and Neta Bomani in 2023 to address a clear gap: Black publishers and artists have long shaped independent publishing, yet we were still underrepresented...

After a senior FDA official claimed that Covid vaccines had caused the deaths of “at least 10 children,” 12 former FDA commissioners released a warning that the claims and policy changes pose “a threat to evidence-based vaccine policy and public health security.”

Small imports that had cleared U.S. customs quickly and easily are now stranded because of changing tariffs and tougher enforcement.

The FDA announced a recall of frozen raw shrimp because of potential exposure to a radioactive isotope.

FDA reviewers of Elon Musk's Neuralink among those fired Current and former FDA officials are worried about safety of trials for Neuralink, other medical devices Feb 17 (Reuters) - U.S. Food and Drug Administration employees reviewing Elon Musk’s brain implant company Neuralink were fired over the weekend as part of a broader purge of the federal workforce, according to two sources with knowledge of the matter. The cuts included about 20 people in the FDA’s office of neurological and physical medicine devices, several of whom worked on Neuralink, according to the two sources, who asked not to be identified because of fear of professional repercussions. That division includes reviewers overseeing clinical-trial applications by Neuralink and other companies making so-called brain-computer interface devices, the sources said. Both sources said they did not believe the employees were specifically targeted because of their work on Neuralink's applications. The loss of roughly 20 employees will hamper the agency’s ability to quickly and safely process medical device applications of all sorts, including Neuralink’s, according to the sources and outside experts. “It’s intimidating to the FDA professionals who are overseeing Neuralink’s trial,” said Victor Krauthamer, a former FDA official for three decades, including a stint as acting director of the office that reviews human-trial requests for brain implants. “We should be worried about the whole trial, and the protection of the people in the trial." In a response to questions, White House spokesman Kush Desai told Reuters the Trump administration "will abide by ethics laws." Trump has said that Musk will excuse himself from any conflicts of interest between his various business interests and his efforts to cut costs for the federal government. The FDA and Musk did not respond to requests for comment. Similar to other government agencies, the cuts affected scientists reviewing medical device applications who were probationary, one of the sources said. Probationary employees typically have less than one year or in some cases less than two years of service and have fewer legal protections. Neuralink is currently testing its device, which allows paralyzed people to use digital devices solely via thought, in a small number of disabled patients. The company is also working on an implant aimed at restoring vision. Last year, the FDA gave that device a designation aimed at speeding up development and federal review, the company has said. After spending more than $250 million to get President Donald Trump re-elected, Musk has been leading a sweeping effort to cut government spending, including at agencies that regulate his companies, such as Tesla (TSLA.O), opens new tab and SpaceX. The dismissal letters sent to the FDA reviewers cited performance reasons, even though the employees had no issues on their prior performance, and had received top-notch rankings several weeks ago, according to the two sources familiar with the matter. The supervisors of the cut employees weren’t consulted before the mass layoffs and found out from their employees, the sources said. Rachael Levy is a Pulitzer Prize-winning enterprise correspondent. She has written about Wall Street, Elon Musk's companies, American health care and national security, among other topics. She earlier reported for the Wall Street Journal and other outlets. Phone: 202-967-6233 Contact her securely on Signal: levy.99 https://www.pulitzer.org/winners/staff-reuters Marisa Taylor, a Pulitzer Prize-winning investigative reporter, has more than two decades of experience covering business, healthcare, the Justice Department, and national security. As a Washington, D.C.-based reporter, she helped break the Panama Papers, which exposed offshore companies linked to more than 140 politicians. Taylor was also part of a team that exposed the CIA’s monitoring of Senate Intelligence Committee staff. She previously reported out of Texas, California, Virginia and Mexico. https://www.pulitzer.org/winners/staff-reuters https://www.reuters.com/authors/marisa-taylor/